CoreCap Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

CoreCap Advisors’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.5K	Hold	500	–	–	﹤0.01%	1760
2026 Q1	$19.3K	Hold	500	–	–	﹤0.01%	1682
2025 Q4	$20.6K	Buy	+500	New	+$19.7K	﹤0.01%	1670

Other funds holding BME

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

CoreCap Advisors's BME Position: Q2 2026 in Review

CoreCap Advisors held its BlackRock Health Sciences Trust (BME) position steady in Q2 2026 at 500 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

CoreCap Advisors first reported a position in BME in Q4 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

CoreCap Advisors held 500 shares of BlackRock Health Sciences Trust worth $21.5K as of Q2 2026.
CoreCap Advisors left its BlackRock Health Sciences Trust share count unchanged in Q2 2026.
BlackRock Health Sciences Trust made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1760 holding.
CoreCap Advisors first reported a position in BlackRock Health Sciences Trust in Q4 2025 and has held it in 3 quarters since.
78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.